Cargando…

Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study

OBJECTIVE: The aim of this exploratory study was to investigate the development of low‐grade inflammation during ageing and its relationship with frailty. METHODS: The trajectories of 18 inflammatory markers measured in blood samples, collected at 5‐year intervals over a period of 20 years from 144...

Descripción completa

Detalles Bibliográficos
Autores principales: Samson, Leonard Daniël, Buisman, Anne‐Marie, Ferreira, José A, Picavet, H Susan J, Verschuren, W M Monique, Boots, Annemieke MH, Engelfriet, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826353/
https://www.ncbi.nlm.nih.gov/pubmed/35154709
http://dx.doi.org/10.1002/cti2.1374
_version_ 1784647413951102976
author Samson, Leonard Daniël
Buisman, Anne‐Marie
Ferreira, José A
Picavet, H Susan J
Verschuren, W M Monique
Boots, Annemieke MH
Engelfriet, Peter
author_facet Samson, Leonard Daniël
Buisman, Anne‐Marie
Ferreira, José A
Picavet, H Susan J
Verschuren, W M Monique
Boots, Annemieke MH
Engelfriet, Peter
author_sort Samson, Leonard Daniël
collection PubMed
description OBJECTIVE: The aim of this exploratory study was to investigate the development of low‐grade inflammation during ageing and its relationship with frailty. METHODS: The trajectories of 18 inflammatory markers measured in blood samples, collected at 5‐year intervals over a period of 20 years from 144 individuals aged 65–75 years at the study endpoint, were related to the degree of frailty later in life. RESULTS: IFN‐γ‐related markers and platelet activation markers were found to change in synchrony. Chronically elevated levels of IL‐6 pathway markers, such as CRP and sIL‐6R, were associated with more frailty, poorer lung function and reduced physical strength. Being overweight was a possible driver of these associations. More and stronger associations were detected in women, such as a relation between increasing sCD14 levels and frailty, indicating a possible role for monocyte overactivation. Multivariate prediction of frailty confirmed the main results, but predictive accuracy was low. CONCLUSION: In summary, we documented temporal changes in and between inflammatory markers in an ageing population over a period of 20 years, and related these to clinically relevant health outcomes.
format Online
Article
Text
id pubmed-8826353
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88263532022-02-11 Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study Samson, Leonard Daniël Buisman, Anne‐Marie Ferreira, José A Picavet, H Susan J Verschuren, W M Monique Boots, Annemieke MH Engelfriet, Peter Clin Transl Immunology Original Article OBJECTIVE: The aim of this exploratory study was to investigate the development of low‐grade inflammation during ageing and its relationship with frailty. METHODS: The trajectories of 18 inflammatory markers measured in blood samples, collected at 5‐year intervals over a period of 20 years from 144 individuals aged 65–75 years at the study endpoint, were related to the degree of frailty later in life. RESULTS: IFN‐γ‐related markers and platelet activation markers were found to change in synchrony. Chronically elevated levels of IL‐6 pathway markers, such as CRP and sIL‐6R, were associated with more frailty, poorer lung function and reduced physical strength. Being overweight was a possible driver of these associations. More and stronger associations were detected in women, such as a relation between increasing sCD14 levels and frailty, indicating a possible role for monocyte overactivation. Multivariate prediction of frailty confirmed the main results, but predictive accuracy was low. CONCLUSION: In summary, we documented temporal changes in and between inflammatory markers in an ageing population over a period of 20 years, and related these to clinically relevant health outcomes. John Wiley and Sons Inc. 2022-02-09 /pmc/articles/PMC8826353/ /pubmed/35154709 http://dx.doi.org/10.1002/cti2.1374 Text en © 2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Article
Samson, Leonard Daniël
Buisman, Anne‐Marie
Ferreira, José A
Picavet, H Susan J
Verschuren, W M Monique
Boots, Annemieke MH
Engelfriet, Peter
Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study
title Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study
title_full Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study
title_fullStr Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study
title_full_unstemmed Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study
title_short Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study
title_sort inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826353/
https://www.ncbi.nlm.nih.gov/pubmed/35154709
http://dx.doi.org/10.1002/cti2.1374
work_keys_str_mv AT samsonleonarddaniel inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy
AT buismanannemarie inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy
AT ferreirajosea inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy
AT picavethsusanj inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy
AT verschurenwmmonique inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy
AT bootsannemiekemh inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy
AT engelfrietpeter inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy